Clear Cell Renal Cell Carcinoma — Trials

Clear Cell Renal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

247 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 114
Recruiting: 62
Ph III recruiting: 6
Growth YoY: −11.4%
Industry share: 30%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 44%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (39)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00326898	Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery(ASSURE)	completed	Phase 3	1,943	National Cancer Institute (NCI)NIH	3	Jun 23, 2026	clinicaltrials
NCT03849118	89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study(89ZR-TLX250)	completed	Phase 3	300	Telix Pharmaceuticals (Innovations) Pty LimitedINDUSTRY	8